Cancer immunotherapy comes of age and looks for maturity

As Nature Communications celebrates a 10-year anniversary, the field has witnessed the transition of cancer immunotherapy from a pipe dream to an established powerful cancer treatment modality. Here we discuss the opportunities and challenges for the future.

Guardado en:
Detalles Bibliográficos
Autores principales: Amanda Finck, Saar I. Gill, Carl H. June
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/b79c612e2f44404b8f5683d98f5ab4b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares